Lpl Financial LLC Unity Biotechnology, Inc. Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.4 - $4.27 $41,836 - $446,603	104,591 New	104,591 $41,000
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.29 $41,804 - $96,298	-74,650 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.72 - $1.86 $41,040 - $106,020	57,000 Added 322.95%	74,650 $84,000
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $22,945 - $55,950	17,650 New	17,650 $26,000
Q2 2021 Aug 13, 2021	SELL	$4.15 - $6.3 $267,928 - $406,734	-64,561 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.51 - $9.42 $892 - $1,526	-162 Reduced 0.25%	64,561 $387,000
Q4 2020 Feb 12, 2021	BUY	$3.42 - $6.36 $2,216 - $4,121	648 Added 1.01%	64,723 $339,000
Q3 2020 Nov 09, 2020	BUY	$2.94 - $12.43 $188,380 - $796,452	64,075 New	64,075 $222,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.